Skip to main content

Immunobullous Diseases: Lessons Learned in the Clinic and at the Microscope



TO ACCESS THIS CONTENT FOR FREE, ENTER THE COUPON CODE AT CHECKOUT: 2021DermLIVE

Original release date:
September 10, 2021
Access to this course expires on:  March 10, 2022 at 11:59 PM Pacific Time
CME .75

Course Description
Differentiating neoplastic from non-neoplastic disorders is one of the most difficult diagnostic challenges in pathology. Accurate diagnosis is paramount to initiate the appropriate treatment. It requires specific skills which often include at least some degree of clinical knowledge, awareness of the broad morphologic range and familiarity with ancillary tests. Errors in the interpretation of skin biopsies, especially in relation to melanocytic tumours, are among the most frequent causes for litigation in surgical biopsy and can lead to unfavorable patient outcomes. There are numerous pitfalls that diagnostic pathologists need to be aware of, including lack of relevant clinical information, sampling error and the wide morphologic spectrum of both inflammatory and neoplastic disorder, often showing overlapping findings and only subtle differentiating features. 

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Recognize the necessity of direct immunofluorescence in the diagnosis of autoimmune blistering diseases
  • Guide clinicians on clinical indications, optimal anatomic site and transport media options for skin biopsy for direct immunofluorescence.
  • Discuss the role of serologic studies in the diagnosis of autoimmune blistering diseases

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Julia S. Lehman, MD 

The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Steven D. Billings, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here.

Not A Member? Click Here

TO ACCESS THIS CONTENT FOR FREE, ENTER THE COUPON CODE AT CHECKOUT: 2021DermLIVE